Saving Time and Money with Transporter Studies
Add bookmark
Saving Time and Money with Transporter Studies
Add bookmark
Dominic Surry, Associate Director of In Vitro Screening & Profiling at AstraZeneca, joins Helen Winsor from Pharma IQ, to discuss clinically relevant drug transporters. He explains the importance of exploring and understanding the forthcoming FDA/EMA regulations in order to develop transporter assays and identify transporter substrates, establish IVIVC and evaluate the clinical relevance. During the interview, he predicts which families of transporters will be the most important for drug d...
Tags:
Dominic Surry
AstraZeneca
In Vitro Screening
Profiling
clinically relevant drug transporters
transporter assays
transporter substrates
IVIVC
pre-clinical transporter data
transporter based DDIs
